The Efficacy of Adebrelimab Compared with Durvalumab and Atezolizumab in Untreated Extensive-Stage Small-Cell Lung Cancer: a Survival Analysis of Reconstructed Patient-Level Data
FRONTIERS IN IMMUNOLOGY（2023）
Key words
PD-L1 inhibitor,survival,first-line,extensive-stage,small-cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined